Evidence map›Paper›PMID 24011989›Full record

ArticleAmerican journal of human genetics2013

Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus.

Pierre Cacciagli, Julie Sutera-Sardo, Ana Borges-Correia, Jean-Christophe Roux, Imen Dorboz, Jean-Pierre Desvignes, Catherine Badens, Marc Delepine, Mark Lathrop, Pierre Cau and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Expanding the Spectrum ofNeurology. Genetics · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. An X-Linked Ataxia Syndrome in a Family with Hearing Loss Associated with a Novel Variant in the BCAP31 Gene.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  9. Strabismus in Genetic Syndromes: A Review.Clinical & experimental ophthalmology · 2025
    Review
  10. Whole exome sequencing reveals a dual diagnosis ofMolecular genetics and metabolism reports · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Case Report: The first Korean familial case ofFrontiers in pediatrics · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Regulation of Superoxide by BAP31 through Its Effect on p22Oxidative medicine and cellular longevity · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Pierre CacciagliINSERM UMR-S 910, Faculté de Médecine Timone, Aix-Marseille Universite, Marseille, France.
Julie Sutera-Sardo
Ana Borges-Correia
Jean-Christophe Roux
Imen Dorboz
Jean-Pierre Desvignes
Catherine Badens
Marc Delepine
Mark Lathrop
Pierre Cau
Nicolas Lévy
Nadine Girard
Pierre Sarda
Odile Boespflug-Tanguy
Laurent Villard
Inserm · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRAix-Marseille Université · FRHôpital Arnaud de Villeneuve · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BAP31 is one of the most abundant endoplasmic reticulum (ER) membrane proteins. It is a chaperone protein involved in several pathways, including ER-associated degradation, export of ER proteins to the Golgi apparatus, and programmed cell death. BAP31 is encoded by BCAP31, located in human Xq28 and highly expressed in neurons. We identified loss-of-function mutations in BCAP31 in seven individuals from three families. These persons suffered from motor and intellectual disabilities, dystonia, sensorineural deafness, and white-matter changes, which together define an X-linked syndrome. In the primary fibroblasts of affected individuals, we found that BCAP31 deficiency altered ER morphology and caused a disorganization of the Golgi apparatus in a significant proportion of cells. Contrary to what has been described with transient-RNA-interference experiments, we demonstrate that constitutive BCAP31 deficiency does not activate the unfolded protein response or cell-death effectors. Rather, our data demonstrate that the lack of BAP31 disturbs ER metabolism and impacts the Golgi apparatus, highlighting an important role for BAP31 in ER-to-Golgi crosstalk. These findings provide a molecular basis for a Mendelian syndrome and link intracellular protein trafficking to severe congenital brain dysfunction and deafness.

Indexed as

Cell ShapeChildChild, PreschoolDeafnessDystoniaFemaleFibroblastsGenetic Diseases, X-LinkedGenetic Predisposition to DiseaseGolgi ApparatusHumansInfantMaleMembrane ProteinsMutationMyelin SheathBCAP31 protein, humanMembrane Proteins

Identifiers

PMID24011989
PMCPMC3769969
OpenAlexW2014154631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.